NOV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
NOV Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show some bullish trends, the company's recent financial performance is weak, and the analyst ratings are mixed. The lack of significant trading signals and the absence of strong positive catalysts make it advisable to hold off on buying this stock for now.
The stock shows some bullish signals with the MACD histogram above 0 (0.0329), positively contracting, and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). RSI is neutral at 59.547. Key resistance levels are at R1: 20.654 and R2: 21.198, while support levels are at S1: 18.893 and S2: 18.349. However, the pre-market price of $20.20 is close to the resistance level, indicating limited short-term upside.
The company has increased its quarterly dividend by 20%, reflecting financial stability and a commitment to shareholder returns. Analysts have raised price targets recently, with some firms maintaining Buy ratings. The stock has an 80% chance of a slight increase (0.1%) in the next day and a higher probability of gains in the next week (6.59%) and month (10.71%).
Additionally, hedge funds and insiders have shown neutral trading activity, and there is no recent congress trading data to indicate confidence from influential figures.
In Q4 2025, NOV Inc. reported a revenue decline of 1.34% YoY to $2.277 billion. Net income dropped significantly to -$78 million (-148.75% YoY), and EPS fell to -$0.21 (-151.22% YoY). Gross margin also decreased to 19.72% (-7.68% YoY). These figures indicate a challenging financial period for the company.
Analyst ratings are mixed, with some firms raising price targets (e.g., TD Cowen to $23 and Susquehanna to $21) and maintaining Buy ratings, while others remain Neutral or In Line. Concerns about 2026 guidance and the company's transition phase have tempered enthusiasm. The average price target is around $20-$21, which aligns with the current pre-market price of $20.20, suggesting limited upside.
